In vitro anticancer drug test: A new method emerges from the model of glioma stem cells

Glioblastoma multiforme (GBM) is a grade IV astrocytoma and the most common malignant brain tumor. Current therapies provide a median survival of 12–15 months after diagnosis, due to the high recurrence rate. The failure of current therapies may be due to the presence, within the tumor, of cells cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Riva, Gabriele, Baronchelli, Simona, Paoletta, Laura, Butta, Valentina, Biunno, Ida, Lavitrano, Marialuisa, Dalprà, Leda, Bentivegna, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598297/
https://www.ncbi.nlm.nih.gov/pubmed/28962238
http://dx.doi.org/10.1016/j.toxrep.2014.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598297/
https://www.ncbi.nlm.nih.gov/pubmed/28962238
http://dx.doi.org/10.1016/j.toxrep.2014.05.005

Ejemplares similares